In this prospective study , 65 women undergoing office endometrial biopsy were randomly allocated to receive 550 mg oral naproxen sodium plus active TENS ( Group I , n = 33 ) or 550 mg oral naproxen sodium plus placebo TENS ( Group II , n = 32 ) .
